{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:27:44Z","timestamp":1795008464372,"version":"4.9.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1038\/s41440-024-01897-z","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T08:03:14Z","timestamp":1726732994000},"page":"200-211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Bilateral adrenal artery embolization for the treatment of idiopathic hyperaldosteronism: A proof-of-principle single center study"],"prefix":"10.1038","volume":"48","author":[{"given":"Guo","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaomin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anping","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"key":"1897_CR1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","volume":"18","author":"AF Turcu","year":"2022","unstructured":"Turcu AF, Yang J, Vaidya A. Primary aldosteronism - a multidimensional syndrome. Nat Rev Endocrinol. 2022;18:665\u201382.","journal-title":"Nat Rev Endocrinol"},{"key":"1897_CR2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3949\/ccjm.88a.20166","volume":"88","author":"A Mehdi","year":"2021","unstructured":"Mehdi A, Rao P, Thomas G. Our evolving understanding of primary aldosteronism. Cleve Clin J Med. 2021;88:221\u20137.","journal-title":"Cleve Clin J Med"},{"key":"1897_CR3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coemr.2019.07.001","volume":"8","author":"N Yozamp","year":"2019","unstructured":"Yozamp N, Vaidya A. The prevalence of primary aldosteronism and evolving approaches for treatment. Curr Opin Endocr Metab Res. 2019;8:30\u20139.","journal-title":"Curr Opin Endocr Metab Res"},{"key":"1897_CR4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","volume":"62","author":"S Savard","year":"2013","unstructured":"Savard S, Amar L, Plouin PF, Steichen O. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension. 2013;62:331\u20136.","journal-title":"Hypertension"},{"key":"1897_CR5","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/HYPERTENSIONAHA.119.14177","volume":"75","author":"K De Sousa","year":"2020","unstructured":"De Sousa K, Boulkroun S, Baron S, Nanba K, Wack M, Rainey WE, et al. Genetic, cellular, and molecular heterogeneity in adrenals with aldosterone-producing adenoma. Hypertension. 2020;75:1034\u201344.","journal-title":"Hypertension"},{"key":"1897_CR6","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","volume":"72","author":"K Omata","year":"2018","unstructured":"Omata K, Satoh F, Morimoto R, Ito S, Yamazaki Y, Nakamura Y, et al. Cellular and genetic causes of idiopathic hyperaldosteronism. Hypertension. 2018;72:874\u201380.","journal-title":"Hypertension"},{"key":"1897_CR7","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. the management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"key":"1897_CR8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","volume":"60","author":"M Reincke","year":"2012","unstructured":"Reincke M, Fischer E, Gerum S, Merkle K, Schulz S, Pallauf A, et al. Observational study mortality in treated primary aldosteronism: the German Conn\u2019s registry. Hypertension. 2012;60:618\u201324.","journal-title":"Hypertension"},{"key":"1897_CR9","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/HJH.0000000000002070","volume":"37","author":"T Katabami","year":"2019","unstructured":"Katabami T, Fukuda H, Tsukiyama H, Tanaka Y, Takeda Y, Kurihara I, et al. Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism. J Hypertens. 2019;37:1513\u201320.","journal-title":"J Hypertens"},{"key":"1897_CR10","doi-asserted-by":"crossref","first-page":"e185842","DOI":"10.1001\/jamasurg.2018.5842","volume":"154","author":"W Vorselaars","year":"2019","unstructured":"Vorselaars W, Nell S, Postma EL, Zarnegar R, Drake FT, Duh QY, et al. Clinical outcomes after unilateral adrenalectomy for primary aldosteronism. JAMA Surg. 2019;154:e185842.","journal-title":"JAMA Surg"},{"key":"1897_CR11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1751-7176.2009.00120.x","volume":"11","author":"M Murashima","year":"2009","unstructured":"Murashima M, Trerotola SO, Fraker DL, Han D, Townsend RR, Cohen DL. Adrenal venous sampling for primary aldosteronism and clinical outcomes after unilateral adrenalectomy: a single-center experience. J Clin Hypertens (Greenwich). 2009;11:316\u201323.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"1897_CR12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","volume":"3","author":"GL Hundemer","year":"2018","unstructured":"Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism. JAMA Cardiol. 2018;3:768\u201374.","journal-title":"JAMA Cardiol"},{"key":"1897_CR13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","volume":"168","author":"C Catena","year":"2008","unstructured":"Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med. 2008;168:80\u20135.","journal-title":"Arch Intern Med"},{"key":"1897_CR14","doi-asserted-by":"crossref","first-page":"625457","DOI":"10.3389\/fendo.2021.625457","volume":"12","author":"Y Tezuka","year":"2021","unstructured":"Tezuka Y, Turcu AF. Real-world effectiveness of mineralocorticoid receptor antagonists in primary aldosteronism. Front Endocrinol (Lausanne). 2021;12:625457.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1897_CR15","volume":"9","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Wang D, Liu Q, Hou J, Wang P. Case report: Percutaneous adrenal arterial embolization cures resistant hypertension. Front Cardiovasc Med. 2022;9:1013426.","journal-title":"Front Cardiovasc Med"},{"key":"1897_CR16","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41440-023-01456-y","volume":"47","author":"K Yokota","year":"2024","unstructured":"Yokota K. Adrenal arterial embolization: a possible new treatment for patients with primary aldosteronism. Hypertens Res. 2024;47:358\u201360.","journal-title":"Hypertens Res"},{"key":"1897_CR17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/pgmj.65.766.575","volume":"65","author":"SB Blunt","year":"1989","unstructured":"Blunt SB, Pirmohamed M, Chatterjee VK, Burrin JM, Allison DJ, Joplin GF. Use of adrenal arterial embolization in severe ACTH-dependent Cushing\u2019s syndrome. Postgrad Med J. 1989;65:575\u20139.","journal-title":"Postgrad Med J"},{"key":"1897_CR18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1148\/radiol.2272011798","volume":"227","author":"H Hokotate","year":"2003","unstructured":"Hokotate H, Inoue H, Baba Y, Tsuchimochi S, Nakajo M. Aldosteronomas: experience with superselective adrenal arterial embolization in 33 cases. Radiology. 2003;227:401\u20136.","journal-title":"Radiology"},{"key":"1897_CR19","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/ccd.29554","volume":"97","author":"H Dong","year":"2021","unstructured":"Dong H, Zou Y, He J, Deng Y, Chen Y, Song L, et al. Superselective adrenal arterial embolization for idiopathic hyperaldosteronism: 12-month results from a proof-of-principle trial. Catheter Cardiovasc Inter. 2021;97:976\u201381.","journal-title":"Catheter Cardiovasc Inter"},{"key":"1897_CR20","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/jch.13960","volume":"22","author":"H Zhang","year":"2020","unstructured":"Zhang H, Li Q, Liu X, Zhao Z, He H, Sun F, et al. Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: An efficacy and safety, proof-of-principle trial. J Clin Hypertens (Greenwich). 2020;22:1618\u201326.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"1897_CR21","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/CIRCULATIONAHA.121.054318","volume":"144","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Liu X, Zhang H, Li Q, He H, Yan Z, et al. Catheter-based adrenal ablation remits primary aldosteronism: a randomized medication-controlled trial. Circulation. 2021;144:580\u20132.","journal-title":"Circulation"},{"key":"1897_CR22","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ajh\/hpac105","volume":"35","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Liu Q, Wang X, Wan J, Liu S, Luo T, et al. Adrenal ablation versus mineralocorticoid receptor antagonism for the treatment of primary aldosteronism: a single-center prospective cohort study. Am J Hypertens. 2022;35:1014\u201323.","journal-title":"Am J Hypertens"},{"key":"1897_CR23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41440-023-01420-w","volume":"47","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Wang X, Hou J, Wan J, Yang Y, Liu S, et al. A controlled trial of percutaneous adrenal arterial embolization for hypertension in patients with idiopathic hyperaldosteronism. Hypertens Res. 2024;47:311\u201321.","journal-title":"Hypertens Res"},{"key":"1897_CR24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","volume":"69","author":"M Naruse","year":"2022","unstructured":"Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, et al. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J. 2022;69:327\u201359.","journal-title":"Endocr J"},{"key":"1897_CR25","doi-asserted-by":"crossref","unstructured":"Wan J, Wang X, Liu S, Hou J, Zhou P, Xue Q, et al. A modified single-catheter approach for improving adrenal venous sampling in patients with primary aldosteronism. J Vasc Access. 2023:11297298231213669.","DOI":"10.1177\/11297298231213669"},{"key":"1897_CR26","volume":"21","author":"J Wan","year":"2021","unstructured":"Wan J, Ran F, Xia S, Hou J, Wang D, Liu S, et al. Feasibility and effectiveness of a single-catheter approach for adrenal vein sampling in patients with primary aldosteronism. BMC Endocr Disord. 2021;21:22.","journal-title":"BMC Endocr Disord"},{"key":"1897_CR27","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3803\/EnM.2021.1192","volume":"36","author":"M Naruse","year":"2021","unstructured":"Naruse M, Tanabe A, Yamamoto K, Rakugi H, Kometani M, Yoneda T, et al. Adrenal venous sampling for subtype diagnosis of primary hyperaldosteronism. Endocrinol Metab (Seoul). 2021;36:965\u201373.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"1897_CR28","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293\u2013300.","journal-title":"J Am Coll Cardiol"},{"key":"1897_CR29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41371-020-00426-y","volume":"35","author":"CH Tsai","year":"2021","unstructured":"Tsai CH, Pan CT, Chang YY, Chen ZW, Wu VC, Hung CS, et al. Left ventricular remodeling and dysfunction in primary aldosteronism. J Hum Hypertens. 2021;35:131\u201347.","journal-title":"J Hum Hypertens"},{"key":"1897_CR30","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/CIRCIMAGING.112.974576","volume":"5","author":"EM Freel","year":"2012","unstructured":"Freel EM, Mark PB, Weir RA, McQuarrie EP, Allan K, Dargie HJ, et al. Demonstration of blood pressure-independent noninfarct myocardial fibrosis in primary aldosteronism: a cardiac magnetic resonance imaging study. Circ Cardiovasc Imaging. 2012;5:740\u20137.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1897_CR31","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/HYPERTENSIONAHA.117.10596","volume":"71","author":"GP Rossi","year":"2018","unstructured":"Rossi GP, Maiolino G, Flego A, Belfiore A, Bernini G, Fabris B, et al. Adrenalectomy lowers incident atrial fibrillation in primary aldosteronism patients at long term. Hypertension. 2018;71:585\u201391.","journal-title":"Hypertension"},{"key":"1897_CR32","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/HYPERTENSIONAHA.118.10759","volume":"71","author":"DA Calhoun","year":"2018","unstructured":"Calhoun DA. Medical versus surgical treatment of primary aldosteronism. Hypertension. 2018;71:566\u20138.","journal-title":"Hypertension"},{"key":"1897_CR33","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41440-019-0244-4","volume":"42","author":"M Satoh","year":"2019","unstructured":"Satoh M, Maruhashi T, Yoshida Y, Shibata H. Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism. Hypertens Res. 2019;42:817\u201324.","journal-title":"Hypertens Res"},{"key":"1897_CR34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2021.03.033","volume":"324","author":"T Haze","year":"2021","unstructured":"Haze T, Hirawa N, Yano Y, Tamura K, Kurihara I, Kobayashi H, et al. Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism. Atherosclerosis. 2021;324:84\u201390.","journal-title":"Atherosclerosis"},{"key":"1897_CR35","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/HYPERTENSIONAHA.119.13463","volume":"74","author":"GP Rossi","year":"2019","unstructured":"Rossi GP, Rossitto G, Amar L, Azizi M, Riester A, Reincke M, et al. Clinical outcomes of 1625 patients with primary aldosteronism subtyped with adrenal vein sampling. Hypertension. 2019;74:800\u20138.","journal-title":"Hypertension"},{"key":"1897_CR36","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1007\/s00464-021-08481-3","volume":"36","author":"O Cano-Valderrama","year":"2022","unstructured":"Cano-Valderrama O, Gonzalez-Nieto J, Abad-Cardiel M, Ochagavia S, Runkle I, Mendez JV, et al. Laparoscopic adrenalectomy vs. radiofrequency ablation for the treatment of primary aldosteronism. A single center retrospective cohort analysis adjusted with propensity score. Surg Endosc. 2022;36:1970\u20138.","journal-title":"Surg Endosc"},{"key":"1897_CR37","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jvir.2019.04.039","volume":"30","author":"KW Liang","year":"2019","unstructured":"Liang KW, Jahangiri Y, Tsao TF, Tyan YS, Huang HH. Effectiveness of thermal ablation for aldosterone-producing adrenal adenoma: a systematic review and meta-analysis of clinical and biochemical parameters. J Vasc Inter Radio. 2019;30:1335\u201342 e1331.","journal-title":"J Vasc Inter Radio"},{"key":"1897_CR38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2214\/AJR.12.9507","volume":"201","author":"AM Fowler","year":"2013","unstructured":"Fowler AM, Burda JF, Kim SK. Adrenal artery embolization: anatomy, indications, and technical considerations. AJR. Am J Roentgenol. 2013;201:190\u2013201.","journal-title":"Am J Roentgenol"},{"key":"1897_CR39","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.2147\/DMSO.S262092","volume":"13","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Liu X, Zhang H, Zhao Z, Li Q, He H, et al. Adrenal artery ablation for the treatment of hypercortisolism based on adrenal venous sampling: a potential therapeutic strategy. Diabetes Metab Syndr Obes. 2020;13:3519\u201325.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1897_CR40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.radcr.2016.10.013","volume":"12","author":"JT Salsamendi","year":"2017","unstructured":"Salsamendi JT, Gortes FJ, Ayala AR, Palacios JD, Tewari S, Narayanan G. Transarterial embolization of a hyperfunctioning aldosteronoma in a patient with bilateral adrenal nodules. Radio Case Rep. 2017;12:87\u201391.","journal-title":"Radio Case Rep."},{"key":"1897_CR41","first-page":"2854","volume":"85","author":"KC Loh","year":"2000","unstructured":"Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young WF Jr. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab. 2000;85:2854\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1897_CR42","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/HYPERTENSIONAHA.118.11203","volume":"71","author":"K Kario","year":"2018","unstructured":"Kario K, Wang JG. Could 130\/80 mm Hg be adopted as the diagnostic threshold and management goal of hypertension in consideration of the characteristics of Asian populations? Hypertension. 2018;71:979\u201384.","journal-title":"Hypertension"},{"key":"1897_CR43","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1093\/eurjpc\/zwaa108","volume":"29","author":"GP Rossi","year":"2022","unstructured":"Rossi GP, Rossitto G, Amar L, Azizi M, Riester A, Reincke M, et al. Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study. Eur J Prev Cardiol. 2022;29:e85\u2013e93.","journal-title":"Eur J Prev Cardiol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01897-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01897-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01897-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T04:36:22Z","timestamp":1736138182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01897-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1897"],"URL":"https:\/\/doi.org\/10.1038\/s41440-024-01897-z","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]},"assertion":[{"value":"3 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}